Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$780M |
| 2 |
Uber
UBER
|
+$708M |
| 3 |
Goldman Sachs
GS
|
+$569M |
| 4 |
Microsoft
MSFT
|
+$430M |
| 5 |
Netflix
NFLX
|
+$415M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$973M |
| 2 |
Intuitive Surgical
ISRG
|
+$872M |
| 3 |
Nike
NKE
|
+$844M |
| 4 |
Edwards Lifesciences
EW
|
+$805M |
| 5 |
Corpay
CPAY
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Consumer Discretionary | 19.04% |
| 3 | Healthcare | 13.04% |
| 4 | Communication Services | 12.22% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Ross Stores
ROST
$80.5B
| $70.6M | 0.09% |
812,304
+83,584
| +11% | +$8.93M |
|
102
Natera
NTRA
$39.4B
| $70M | 0.09% |
2,343,918
-188,437
| -7% | -$6.3M |
|
|
NVO
103
Novo Nordisk
NVO
$196B
| $69.4M | 0.08% |
2,305,220
+40,552
| +2% | +$1.21M |
|
|
IMMU
104
DELISTED
Immunomedics Inc
IMMU
| $67.7M | 0.08% |
5,021,294
+1,997,717
| +66% | +$33.6M |
|
105
Bristol-Myers Squibb
BMY
$135B
| $67.7M | 0.08% |
1,213,741
+622,193
| +105% | +$38M |
|
106
Saia
SAIA
$9.99B
| $67.2M | 0.08% |
914,185
-41,582
| -4% | -$3.65M |
|
107
NiSource
NI
$21.3B
| $66.3M | 0.08% |
2,654,084
-399,457
| -13% | -$11M |
|
|
SUM
108
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $66M | 0.08% |
4,475,645
+72,023
| +2% | +$1.4M |
|
109
American Water Works
AWK
$26.6B
| $64.9M | 0.08% |
542,451
+19,215
| +4% | +$2.48M |
|
110
AT&T
T
$160B
| $64.2M | 0.08% |
2,916,765
+613,167
| +27% | +$16.8M |
|
111
Conagra Brands
CAG
$7.18B
| $63M | 0.08% |
2,148,381
-2,242
| -0.1% | -$67.6K |
|
|
HRC
112
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $62.8M | 0.08% |
624,504
-83,351
| -12% | -$8.63M |
|
113
SAP
SAP
$226B
| $62.8M | 0.08% |
568,220
-1,148,926
| -67% | -$145M |
|
114
Quanta Services
PWR
$104B
| $62.4M | 0.08% |
1,965,749
-27,499
| -1% | -$1.02M |
|
|
FISV
115
Fiserv Inc
FISV
$29.7B
| $62M | 0.08% |
652,693
+57,318
| +10% | +$6.37M |
|
|
PFPT
116
DELISTED
Proofpoint, Inc.
PFPT
| $61.9M | 0.08% |
603,515
+4,456
| +0.7% | +$520K |
|
117
Marvell Technology
MRVL
$196B
| $61.6M | 0.07% |
2,723,428
-810,298
| -23% | -$19.4M |
|
118
Exelon
EXC
$47.2B
| $61.4M | 0.07% |
2,338,717
+55,064
| +2% | +$1.73M |
|
119
RTX Corp
RTX
$294B
| $61.1M | 0.07% |
1,028,847
-428,345
| -29% | -$36.3M |
|
|
RDS.A
120
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $60.9M | 0.07% |
1,746,796
+129,822
| +8% | +$6.06M |
|
|
HZNP
121
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $59.1M | 0.07% |
1,995,141
+37,787
| +2% | +$1.28M |
|
122
Pinnacle Financial Partners Inc
PNFP
$16.5B
| $58.6M | 0.07% |
1,562,216
-425,467
| -21% | -$23M |
|
123
Abbott
ABT
$182B
| $58.2M | 0.07% |
738,033
-1,418,501
| -66% | -$118M |
|
|
QTS
124
DELISTED
QTS REALTY TRUST, INC.
QTS
| $58.1M | 0.07% |
1,000,892
+61,449
| +7% | +$3.43M |
|
125
Centene
CNC
$31.7B
| $57.5M | 0.07% |
967,460
-117,259
| -11% | -$7.11M |
|
Similar funds
Jennison Associates's Q1 2020 Portfolio in Review
As of Q1 2020, Jennison Associates held 749 positions worth $82.3B, down 17% from $99.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates withdrew a net $4.86B in Q1 2020, closing 131 positions and reducing 247 holdings. Its most notable exit was Parker-Hannifin, an estimated $116M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Atlassian worth $350M.
- Jennison Associates's largest Q1 2020 buy was Atlassian: 2,552,272 shares worth $350M.
- Jennison Associates added most to Eli Lilly in Q1 2020, an estimated $780M increase.
- Jennison Associates's biggest Q1 2020 reduction was Walt Disney, cutting an estimated $973M.
- Jennison Associates fully exited Parker-Hannifin in Q1 2020, selling an estimated $116M.
- Jennison Associates's ten largest holdings make up 40% of its $82.3B portfolio in Q1 2020.
- Jennison Associates opened 131 new positions and closed 131 in Q1 2020.
- Jennison Associates's portfolio value fell 17% quarter-over-quarter to $82.3B.
Based on Jennison Associates's 13F filing for Q1 2020, filed 6 May 2020.